0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query technavio global her 2 positive breast cancer market 2015 2019.Your search for "" gave back 1533058 results.
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2019 Summary Toll Like Receptor 8 (CD288 or TLR8) pipeline Target constitutes close to 22...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Pyrotinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Palbociclib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global HER2 Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global HER2 Antibodies market size was valued at US$ 8106.9 million in 2023. With growing demand in downstream market, the HER2 Antibodies is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Market Analysis and Insights: Global Targeted Drugs for Breast Cancer Market The global Targeted Drugs for Breast Cancer market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global HER2 Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of %...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The “Bispecific Antibody Molecular Drug Industry Forecast” looks at past sales and reviews total world Bispecific Antibody Molecular Drug sales in...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
